A phase 3 double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of AB-205 plus standard of care (SOC) versus placebo plus standard of care in adults with lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (E-CELERATE) (NCT05181540) - Trials in progress Meeting Abstract
| Authors: | Scordo, M.; Shouse, G.; Mountjoy, L.; Gauthier, J.; Dholaria, B.; Rowley, S. D.; Pantin, J. M.; Defilipp, Z.; Mead, M.; Finnegan, P. |
| Abstract Title: | A phase 3 double-blind, randomized, placebo controlled study to evaluate the efficacy and safety of AB-205 plus standard of care (SOC) versus placebo plus standard of care in adults with lymphoma undergoing high-dose therapy and autologous hematopoietic cell transplantation (E-CELERATE) (NCT05181540) - Trials in progress |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 10573 |
| End Page: | 10574 |
| Language: | English |
| ACCESSION: | WOS:000893230303255 |
| DOI: | 10.1182/blood-2022-162373 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
